TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.727
EU - Europa 848
AS - Asia 191
SA - Sud America 6
OC - Oceania 1
Totale 2.773
Nazione #
US - Stati Uniti d'America 1.700
IT - Italia 208
DE - Germania 204
IE - Irlanda 197
CN - Cina 122
SE - Svezia 104
CA - Canada 27
GB - Regno Unito 27
HK - Hong Kong 24
AT - Austria 23
FI - Finlandia 21
UA - Ucraina 19
TR - Turchia 16
RU - Federazione Russa 13
VN - Vietnam 13
BE - Belgio 11
DK - Danimarca 10
IN - India 6
JP - Giappone 6
FR - Francia 4
NL - Olanda 4
CL - Cile 3
BR - Brasile 2
SG - Singapore 2
AU - Australia 1
BG - Bulgaria 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
KZ - Kazakistan 1
RO - Romania 1
Totale 2.773
Città #
Ann Arbor 508
Chandler 196
Dublin 192
Frankfurt am Main 186
Woodbridge 167
Fairfield 129
Wilmington 90
Ashburn 68
New York 67
Seattle 49
Houston 48
Princeton 48
Milan 45
Cambridge 41
Jacksonville 39
Lissone 34
Dearborn 30
Shanghai 30
Hong Kong 24
Altamura 23
Vienna 23
Lawrence 22
Nanjing 16
Beijing 15
Brussels 11
Lachine 11
Ottawa 10
Andover 9
Boardman 9
Caronno Pertusella 9
Helsinki 9
London 9
San Diego 9
Hangzhou 8
Shenyang 7
Changsha 5
Jinan 5
Toronto 5
Bellaria-Igea Marina 4
Hebei 4
Norwalk 4
Pune 4
Sacramento 4
Zhengzhou 4
Detroit 3
Guangzhou 3
Lardirago 3
Odense 3
Piacenza 3
Sesto San Giovanni 3
Brescia 2
Cesano Maderno 2
Cinisello Balsamo 2
Corbara 2
Cremona 2
Fremont 2
Genoa 2
Grassobbio 2
Jiaxing 2
Kunming 2
Los Angeles 2
Monza 2
Nihon'odori 2
Orange 2
Padova 2
Redmond 2
Rome 2
Seregno 2
Tokyo 2
Almaty 1
Belvedere Spinello 1
Bonndorf 1
Boston 1
Brugherio 1
Campinas 1
Cantù 1
Chengdu 1
Chicago 1
Cusano Milanino 1
Dalmine 1
Edmonton 1
Fuzhou 1
Genova 1
Groningen 1
Hanover 1
Hefei 1
Huizen 1
Iasi 1
Kemerovo 1
Kiev 1
Kilburn 1
Kocaeli 1
Kundan 1
Kyoto 1
Lappeenranta 1
Leawood 1
Legnano 1
Lexington 1
Melbourne 1
Mountain View 1
Totale 2.317
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 206
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 198
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 167
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 145
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 145
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 135
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 130
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 128
Immunology of membranous nephropathy: From animal models to humans 123
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 119
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 116
Neutrophil Extracellular Traps in the Autoimmunity Context 116
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 106
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 105
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 103
ANCA-associated vasculitides (AAV) from the gender point of view 101
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 100
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 91
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 88
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 78
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 77
Novel Therapies in Takayasu Arteritis 70
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 56
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 50
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 47
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 34
Evidence for charge-based mimicry in anti dsDNA antibody generation 30
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 23
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 22
Totale 2.909
Categoria #
all - tutte 8.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 5 4 6 10 10
2019/2020199 30 5 6 4 11 18 19 21 21 20 26 18
2020/2021651 12 23 111 53 40 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023756 69 236 101 60 45 105 15 47 45 10 15 8
2023/2024452 18 14 37 25 60 183 103 12 0 0 0 0
Totale 2.909